These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33856784)

  • 1. Binding Characterization of Agonists and Antagonists by MCCS: A Case Study from Adenosine A
    Cheng J; Chen M; Wang S; Liang T; Chen H; Chen CJ; Feng Z; Xie XQ
    ACS Chem Neurosci; 2021 May; 12(9):1606-1620. PubMed ID: 33856784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex.
    Katritch V; Rueda M; Lam PC; Yeager M; Abagyan R
    Proteins; 2010 Jan; 78(1):197-211. PubMed ID: 20063437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptor as a drug discovery target.
    de Lera Ruiz M; Lim YH; Zheng J
    J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacy.
    Bennett KA; Tehan B; Lebon G; Tate CG; Weir M; Marshall FH; Langmead CJ
    Mol Pharmacol; 2013 May; 83(5):949-58. PubMed ID: 23429888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
    Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
    Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Therapeutic Applications of Adenosine A
    van Waarde A; Dierckx RAJO; Zhou X; Khanapur S; Tsukada H; Ishiwata K; Luurtsema G; de Vries EFJ; Elsinga PH
    Med Res Rev; 2018 Jan; 38(1):5-56. PubMed ID: 28128443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Santinelli C; Spinaci A; Thomas A; Volpini R
    Mol Inform; 2016 Sep; 35(8-9):403-13. PubMed ID: 27546044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
    Margiotta E; Deganutti G; Moro S
    J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isothermal chemical denaturation to determine binding affinity of small molecules to G-protein coupled receptors.
    Ross P; Weihofen W; Siu F; Xie A; Katakia H; Wright SK; Hunt I; Brown RK; Freire E
    Anal Biochem; 2015 Mar; 473():41-5. PubMed ID: 25481736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.
    Keränen H; Gutiérrez-de-Terán H; Åqvist J
    PLoS One; 2014; 9(10):e108492. PubMed ID: 25285959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Modulation of Adenosine A
    Korkutata M; Agrawal L; Lazarus M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.
    Jespers W; Heitman LH; IJzerman AP; Sotelo E; van Westen GJP; Åqvist J; Gutiérrez-de-Terán H
    PLoS Comput Biol; 2021 Nov; 17(11):e1009152. PubMed ID: 34818333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum.
    Orrú M; Quiroz C; Guitart X; Ferré S
    Neuropharmacology; 2011; 61(5-6):967-74. PubMed ID: 21752341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.